09:25 29-11-2014
MAIN Russian
About us On-line subscription
KazakhstanTajikistanUzbekistanKyrgyzstanTurkmenistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
Drug to crack resistant TB

Bishkek (AKIpress) - doctor-x-ray Florian von Groote-Bidlingmaier, medical director of TASK Applied Science, a research unit collaborating with Stellenbosch University, told doctors yesterday about trials of new drugs that might offer a lifeline to patients with drug-resistant TB, Times Live reported.

He was speaking at the World TB Day Symposium, convened by the National Institute for Communicable Diseases, in Johannesburg.

Half-a-million South Africans contract TB every year and one in 25 is likely to develop a form of the disease resistant to treatment. Drug-resistant TB kills at least one in five of the people who contract it.

Most TB drugs have been in use for at least 50 years, Von Groote-Bidlingmaier said, but the development of a new medicine took many years and could cost as much as 10 billion rand ($920.3 million).

It can be years before patients gain access to a new medicine. For example, the drug bedaquiline was developed in 2005 but almost 10 years later it is available to only 200 patients in South Africa in a monitored program with strict eligibility criteria.

Von Groote-Bidlingmaier said that delamanid, conditionally approved by the European Medicines Agency recently, was being tested at three sites in South Africa and abroad. The current trials, if successful, are the last step before the drug is registered.

“TB is not treated with a single drug. There is a need for further trials to test new drugs in combination to see if we can find a better treatment regimen.”

South Africa is the world leader in the exploitation of the GeneXpert machine to detect TB much more quickly. But a study has shown that, though detection has improved, patients are no more likely to start and see their treatment through to completion.

TASK Applied Science performs clinical trials in tuberculosis (TB) in Cape Town, South Africa. TASK can provide assistance to efficiently conduct studies for diagnosis, treatment or prevention of tuberculosis.


Twitterfacebookprint
13:01 25.03.2014
LATEST NEWS
15:43 Trial against alleged IS recruiter starts in Uzbekistan: authorities15:13 Damu Fund approves business support program for processing industry14:52 Volcano in south Japan erupts, disrupting flights14:47 Former mayor of Osh City declared wanted14:31 Kyrgyz sportsman wins silver at 2014 World Grappling Championships in Moscow14:21 Vietnam could become first state to sign free trade zone deal with Eurasian Customs Union - Putin14:15 Nazarbayev, National Security Committee chairman discuss fight against terrorism and extremism14:08 Bishkek to host concert of Sofia Philharmonic Orchestra soloist13:58 Afghan suicide attack hits UK embassy car in Kabul13:48 President signs law on guaranteed transfer from Kazakhstan's National Fund in 2015-201713:41 President of Kazakhstan approves law on state budget 2015-201713:25 KazTransGas puts Zharkum deposit into trial operation13:12 Tajik security agency says it has revealed a group of students involved in Group 2413:00 Tajikistan, France discuss cooperation issues amid ISAF withdrawal from Afghanistan12:48 China overtakes Japan as world’s second-biggest stock market12:42 Tajik Ambassador to Slovakia presents his credentials to President Kiska12:29 USAID to hold several events in Kyrgyzstan to mark World AIDS Day12:22 Uzbekistan's art of wit Askiya included into UNESCO Representative List of Intangible Cultural Heritage11:47 Kyrgyzstan one of 7 world countries with highest HIV and AIDS growth rates – analysis11:35 OSCE Centre in Astana facilitates meeting on application of administrative sanctions
Astana
-18° C
Ashgabat
+5° C
Bishkek
-7° C
Dushanbe
+7° C
Tashkent
+4° C
exchange rates
 
71.88
57.58
9.40
1.21
225.58
180.87
29.46
3.79
6.31
5.08
0.83
0.11
3042.15
2388.25
390.42
56.91
3.54
2.85
0.46
0.06

© AKIpress News Agency - 2001-2014
Use of the AKIpress.com materials must be accompanied by a hyperlink to www.akipress.com
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75